For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associa ...

A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

The combined regimen achieved a higher remission rate than calorie restriction alone in people with overweight or obesity and ...

Depending on the group, participants either received 10 mg of dapagliflozin or placebo per day for 12 months. All participants were instructed to follow a calorie restriction diet with an energy ...

As part of the pact, Sun Pharma will sell AstraZeneca's dapagliflozin, a Type 2 diabetes medicine, under brand name Oxra. AstraZeneca India markets dapagliflozin under the brand name Forxiga.